| Pathogenesis and therapy of psoriasis MA Lowes, AM Bowcock, JG Krueger Nature 445 (7130), 866-873, 2007 | 1925 | 2007 |
| Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells MA Lowes, T Kikuchi, J Fuentes-Duculan, I Cardinale, LC Zaba, ... Journal of Investigative Dermatology 128 (5), 1207-1211, 2008 | 1167 | 2008 |
| Immunology of psoriasis MA Lowes, M Suarez-Farinas, JG Krueger Annual review of immunology 32, 227-255, 2014 | 1099 | 2014 |
| Brodalumab, an anti–interleukin-17–receptor antibody for psoriasis KA Papp, C Leonardi, A Menter, JP Ortonne, JG Krueger, G Kricorian, ... New England Journal of Medicine 366 (13), 1181-1189, 2012 | 1040 | 2012 |
| Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris E Lee, WL Trepicchio, JL Oestreicher, D Pittman, F Wang, F Chamian, ... The Journal of experimental medicine 199 (1), 125-130, 2004 | 1028 | 2004 |
| Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes RM Grossman, J Krueger, D Yourish, A Granelli-Piperno, DP Murphy, ... Proceedings of the National Academy of Sciences 86 (16), 6367-6371, 1989 | 980 | 1989 |
| The immunologic basis for the treatment of psoriasis with new biologic agents JG Krueger Journal of the American Academy of Dermatology 46 (1), 1-26, 2002 | 926 | 2002 |
| Th17 cytokines interleukin (IL)‐17 and IL‐22 modulate distinct inflammatory and keratinocyte‐response pathways KE Nograles, LC Zaba, E Guttman‐Yassky, J Fuentes‐Duculan, ... British Journal of Dermatology 159 (5), 1092-1102, 2008 | 798 | 2008 |
| A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci Y Liu, C Helms, W Liao, LC Zaba, S Duan, J Gardner, C Wise, A Miner, ... PLoS genetics 4 (4), e1000041, 2008 | 741 | 2008 |
| Psoriasis pathophysiology: current concepts of pathogenesis JG Krueger, A Bowcock Annals of the rheumatic diseases 64 (suppl 2), ii30-ii36, 2005 | 741 | 2005 |
| CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris JR Abrams, MG Lebwohl, CA Guzzo, BV Jegasothy, MT Goldfarb, ... The Journal of clinical investigation 103 (9), 1243-1252, 1999 | 728 | 1999 |
| Response of psoriasis to a lymphocyte-selective toxin (DAB 389 IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis SL Gottlieb, P Gilleaudeau, R Johnson, L Estes, TG Woodworth, ... Nature medicine 1 (5), 442-447, 1995 | 716 | 1995 |
| Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions BB Davidovici, N Sattar, PC Jörg, L Puig, P Emery, JN Barker, ... Journal of Investigative Dermatology 130 (7), 1785-1796, 2010 | 703 | 2010 |
| Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses LC Zaba, I Cardinale, P Gilleaudeau, M Sullivan-Whalen, ... The Journal of experimental medicine 204 (13), 3183-3194, 2007 | 695 | 2007 |
| IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells KE Nograles, LC Zaba, A Shemer, J Fuentes-Duculan, I Cardinale, ... Journal of Allergy and Clinical Immunology 123 (6), 1244-1252. e2, 2009 | 658 | 2009 |
| Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis JK Gittler, A Shemer, M Suárez-Fariñas, J Fuentes-Duculan, KJ Gulewicz, ... Journal of Allergy and Clinical Immunology 130 (6), 1344-1354, 2012 | 649 | 2012 |
| Getting under the skin: the immunogenetics of psoriasis AM Bowcock, JG Krueger Nature Reviews Immunology 5 (9), 699-711, 2005 | 630 | 2005 |
| The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (Cytotoxic … LM Austin, M Ozawa, T Kikuchi, IB Walters, JG Krueger Journal of Investigative Dermatology 113 (5), 752-759, 1999 | 625 | 1999 |
| Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a) MA Lowes, F Chamian, MV Abello, J Fuentes-Duculan, SL Lin, ... Proceedings of the National Academy of Sciences 102 (52), 19057-19062, 2005 | 528 | 2005 |
| 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions M Ozawa, K Ferenczi, T Kikuchi, I Cardinale, LM Austin, TR Coven, ... The Journal of experimental medicine 189 (4), 711-718, 1999 | 519 | 1999 |
